The mutagenic activity of human breast secretions.
作者信息
Scott W N, Miller W R
机构信息
Department of Surgery, Royal Infirmary, Edinburgh, United Kingdom.
出版信息
J Cancer Res Clin Oncol. 1990;116(5):499-502. doi: 10.1007/BF01613001.
Abstract
Human breast secretions, as obtained by nipple aspiration, were analysed for the presence of mutagenic activity by means of the Ames test. The overall incidence of women with secretions giving positive tests against Salmonella typhimurium, either strain TA98 or TA100, was 7.64%. No significant association was identified between the incidence of mutagen-positive breast secretions and age, menopausal status or the presence of breast abnormality in these women. Furthermore, there was no obvious environmental characteristic common to women with mutagen-positive fluids.
摘要
相似文献
1
The mutagenic activity of human breast secretions.
J Cancer Res Clin Oncol. 1990;116(5):499-502. doi: 10.1007/BF01613001.
2
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨治疗药物。
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD003474. doi: 10.1002/14651858.CD003474.pub4.
3
Combination versus sequential single agent chemotherapy for metastatic breast cancer.转移性乳腺癌的联合化疗与序贯单药化疗对比研究
Cochrane Database Syst Rev. 2013 Dec 18;2013(12):CD008792. doi: 10.1002/14651858.CD008792.pub2.
4
Treatments for breast abscesses in breastfeeding women.哺乳期妇女乳房脓肿的治疗方法。
Cochrane Database Syst Rev. 2015 Aug 17;2015(8):CD010490. doi: 10.1002/14651858.CD010490.pub2.
5
Interventions for fertility preservation in women with cancer undergoing chemotherapy.对接受化疗的癌症女性进行生育力保存的干预措施。
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
6
Specialist breast care nurses for support of women with breast cancer.专科乳腺护理护士为乳腺癌女性提供支持。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD005634. doi: 10.1002/14651858.CD005634.pub3.
7
Breastfeeding or nipple stimulation for reducing postpartum haemorrhage in the third stage of labour.母乳喂养或乳头刺激用于减少分娩第三产程中的产后出血。
Cochrane Database Syst Rev. 2016 Jan 27;2016(1):CD010845. doi: 10.1002/14651858.CD010845.pub2.
8
Tamoxifen for early breast cancer.他莫昔芬用于早期乳腺癌。
Cochrane Database Syst Rev. 2001(1):CD000486. doi: 10.1002/14651858.CD000486.
9
WITHDRAWN: Tamoxifen for early breast cancer.撤回：他莫昔芬用于早期乳腺癌。
Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD000486. doi: 10.1002/14651858.CD000486.pub2.
10
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
引用本文的文献
1
Nipple Aspirate Fluid at a Glance.乳头抽吸液概览
Cancers (Basel). 2021 Dec 29;14(1):159. doi: 10.3390/cancers14010159.
2
DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry.液相色谱/串联质谱法检测人乳组织中 2-氨基-1-甲基-6-苯基咪唑[4,5-b]吡啶和 4-氨基联苯的 DNA 加合物的频率较低。
Carcinogenesis. 2012 Jan;33(1):124-30. doi: 10.1093/carcin/bgr252. Epub 2011 Nov 9.
3
Analysis association between mitochondrial genome instability and xenobiotic metabolizing genes in human breast cancer.人类乳腺癌中线粒体基因组不稳定性与外源性物质代谢基因之间的关联分析。
Mol Med. 2009 May-Jun;15(5-6):160-5. doi: 10.2119/molmed.2008.00136. Epub 2009 Mar 6.
4
Cathepsin D in breast secretions from women with breast cancer.乳腺癌女性乳腺分泌物中的组织蛋白酶D
Br J Cancer. 1993 May;67(5):1076-81. doi: 10.1038/bjc.1993.197.
5
Mutagens in human breast cyst fluid.人乳腺囊肿液中的诱变剂。
J Cancer Res Clin Oncol. 1991;117(3):254-8. doi: 10.1007/BF01625434.
6
Factors affecting protein composition of breast secretions from nonlactating women.
Breast Cancer Res Treat. 1992;23(3):251-8. doi: 10.1007/BF01833522.
本文引用的文献
1
Mutagenic activity in nipple aspirates of human breast fluid.
Cancer Res. 1980 Jan;40(1):188-9.
2
Breast carcinoma etiological factors.乳腺癌的病因
Adv Cancer Res. 1983;40:189-253. doi: 10.1016/s0065-230x(08)60681-8.
3
Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.用沙门氏菌/哺乳动物微粒体诱变性试验检测致癌物和诱变剂的方法。
Mutat Res. 1975 Dec;31(6):347-64. doi: 10.1016/0165-1161(75)90046-1.
Zotero 插件